These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 8011811

  • 1. Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia.
    Caumes E, Roudier C, Rogeaux O, Bricaire F, Gentilini M.
    Clin Infect Dis; 1994 Mar; 18(3):319-23. PubMed ID: 8011811
    [Abstract] [Full Text] [Related]

  • 2. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ.
    Gluckstein D, Ruskin J.
    Clin Infect Dis; 1995 Apr; 20(4):849-53. PubMed ID: 7795084
    [Abstract] [Full Text] [Related]

  • 3. Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS.
    Carr A, Swanson C, Penny R, Cooper DA.
    J Infect Dis; 1993 Jan; 167(1):180-5. PubMed ID: 8380290
    [Abstract] [Full Text] [Related]

  • 4. Clindamycin with primaquine vs. Trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group.
    Toma E, Thorne A, Singer J, Raboud J, Lemieux C, Trottier S, Bergeron MG, Tsoukas C, Falutz J, Lalonde R, Gaudreau C, Therrien R.
    Clin Infect Dis; 1998 Sep; 27(3):524-30. PubMed ID: 9770152
    [Abstract] [Full Text] [Related]

  • 5. Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol 029/031.
    Sattler FR, Frame P, Davis R, Nichols L, Shelton B, Akil B, Baughman R, Hughlett C, Weiss W, Boylen CT.
    J Infect Dis; 1994 Jul; 170(1):165-72. PubMed ID: 8014493
    [Abstract] [Full Text] [Related]

  • 6. Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis.
    Veenstra J, Veugelers PJ, Keet IP, van der Ven AJ, Miedema F, Lange JM, Coutinho RA.
    Clin Infect Dis; 1997 May; 24(5):936-41. PubMed ID: 9142796
    [Abstract] [Full Text] [Related]

  • 7. Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia.
    Hughes WT, LaFon SW, Scott JD, Masur H.
    J Infect Dis; 1995 May; 171(5):1295-301. PubMed ID: 7751706
    [Abstract] [Full Text] [Related]

  • 8. Combination of Echinocandins and Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jiroveci Pneumonia After Heart Transplantation.
    Lu YM, Lee YT, Chang HC, Yang HS, Chang CY, Huang CM, Wei J.
    Transplant Proc; 2017 Oct; 49(8):1893-1898. PubMed ID: 28923644
    [Abstract] [Full Text] [Related]

  • 9. Adverse cutaneous reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia.
    Roudier C, Caumes E, Rogeaux O, Bricaire F, Gentilini M.
    Arch Dermatol; 1994 Nov; 130(11):1383-6. PubMed ID: 7979438
    [Abstract] [Full Text] [Related]

  • 10. High daily doses of trimethoprim/sulfamethoxazole are an independent risk factor for adverse reactions in patients with pneumocystis pneumonia and AIDS.
    Chang HM, Tsai HC, Lee SS, Kunin C, Lin PC, Wann SR, Chen YS.
    J Chin Med Assoc; 2016 Jun; 79(6):314-9. PubMed ID: 27025225
    [Abstract] [Full Text] [Related]

  • 11. Use of trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonitis in patients with acquired immunodeficiency syndrome.
    Wofsy CB.
    Rev Infect Dis; 1987 Jun; 9 Suppl 2():S184-94. PubMed ID: 3554457
    [Abstract] [Full Text] [Related]

  • 12. Trimethoprim-sulfamethoxazole therapy for Pneumocystis carinii pneumonitis in children.
    Hughes WT.
    Rev Infect Dis; 1982 Jun; 4(2):602-7. PubMed ID: 6981176
    [Abstract] [Full Text] [Related]

  • 13. A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital.
    Li H, Lu Y, Tian G, Wu Y, Chen T, Zhang J, Hu N, Wang X, Wang Y, Gao L, Yan J, Zhou L, Shi Q.
    BMC Infect Dis; 2024 Jan 31; 24(1):152. PubMed ID: 38297200
    [Abstract] [Full Text] [Related]

  • 14. Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268.
    Para MF, Finkelstein D, Becker S, Dohn M, Walawander A, Black JR.
    J Acquir Immune Defic Syndr; 2000 Aug 01; 24(4):337-43. PubMed ID: 11015150
    [Abstract] [Full Text] [Related]

  • 15. A Pilot Study of Echinocandin Combination with Trimethoprim/Sulfamethoxazole and Clindamycin for the Treatment of AIDS Patients with Pneumocystis Pneumonia.
    Wang M, Lang G, Chen Y, Hu C, Guo Y, Tao R, Dong X, Zhu B.
    J Immunol Res; 2019 Aug 01; 2019():8105075. PubMed ID: 31886310
    [Abstract] [Full Text] [Related]

  • 16. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ, Hauptman SP.
    Clin Pharm; 1988 Jul 01; 7(7):514-27. PubMed ID: 3138063
    [Abstract] [Full Text] [Related]

  • 17. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
    Tu GW, Ju MJ, Xu M, Rong RM, He YZ, Xue ZG, Zhu TY, Luo Z.
    Nephrology (Carlton); 2013 Nov 01; 18(11):736-42. PubMed ID: 24571744
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: A retrospective multicenter study.
    Ohmura SI, Naniwa T, Tamechika SY, Miyamoto T, Shichi D, Kazawa N, Iwagaitsu S, Maeda S, Wada JI, Niimi A.
    J Infect Chemother; 2019 Apr 01; 25(4):253-261. PubMed ID: 30642768
    [Abstract] [Full Text] [Related]

  • 19. Successful treatment of severe Pneumocystis pneumonia in an immunosuppressed patient using caspofungin combined with clindamycin: a case report and literature review.
    Li H, Huang H, He H.
    BMC Pulm Med; 2016 Nov 11; 16(1):144. PubMed ID: 27835947
    [Abstract] [Full Text] [Related]

  • 20. Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double-blind pilot trial.
    Toma E, Fournier S, Dumont M, Bolduc P, Deschamps H.
    Clin Infect Dis; 1993 Aug 11; 17(2):178-84. PubMed ID: 8399863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.